Oak Ridge Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-68,415
Closed -$1.89M 165
2022
Q1
$1.89M Sell
68,415
-39,433
-37% -$1.13M 0.21% 102
2021
Q4
$4.44M Sell
107,848
-1,818
-2% -$80.3K 0.38% 83
2021
Q3
$5.09M Sell
109,666
-3,680
-3% -$161K 0.45% 74
2021
Q2
$4.53M Sell
113,346
-6,984
-6% -$299K 0.4% 89
2021
Q1
$6.47M Sell
120,330
-4,040
-3% -$233K 0.6% 65
2020
Q4
$6.09M Sell
124,370
-29,094
-19% -$1.35M 0.54% 69
2020
Q3
$4.99M Buy
+153,464
New +$4.88M 0.39% 92

Other funds holding VCYT

Oak Ridge Investments's VCYT Position: Q2 2022 in Review

Oak Ridge Investments sold out of Veracyte (VCYT) in Q2 2022, closing a stake of 68,415 shares — an estimated $1.89M sold.

Oak Ridge Investments first reported a position in VCYT in Q3 2020 and held it in 7 quarters. The position peaked at $6.47M in Q1 2021. 193 funds tracked by Wall St. Rank hold VCYT as of Q2 2022.

  • Oak Ridge Investments reported no remaining Veracyte position as of Q2 2022 after selling out during the quarter.
  • Oak Ridge Investments sold 68,415 Veracyte shares in Q2 2022, an estimated $1.89M.
  • Oak Ridge Investments first reported a position in Veracyte in Q3 2020 and held it in 7 quarters.
  • Oak Ridge Investments's Veracyte position peaked at $6.47M in Q1 2021.
  • 193 funds tracked by Wall St. Rank held Veracyte as of Q2 2022.

Based on Oak Ridge Investments's 13F filing for Q2 2022, filed 28 Jul 2022.